UA99746C2 - Кристаллическое химиотерапевтическое средство на основе индазола - Google Patents

Кристаллическое химиотерапевтическое средство на основе индазола

Info

Publication number
UA99746C2
UA99746C2 UAA201006033A UAA201006033A UA99746C2 UA 99746 C2 UA99746 C2 UA 99746C2 UA A201006033 A UAA201006033 A UA A201006033A UA A201006033 A UAA201006033 A UA A201006033A UA 99746 C2 UA99746 C2 UA 99746C2
Authority
UA
Ukraine
Prior art keywords
indazole
crystalline
derived chemotherapeutic
chemotherapeutic
derived
Prior art date
Application number
UAA201006033A
Other languages
English (en)
Ukrainian (uk)
Inventor
Томас Б. Борчардт
Александр Чу-Кунг
Майкл Дж. Розема
Шаилендра В. Бордавекар
Original Assignee
Эбботт Лабораториз
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40090209&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA99746(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Эбботт Лабораториз filed Critical Эбботт Лабораториз
Publication of UA99746C2 publication Critical patent/UA99746C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Описаны кристаллическая форма 1 гидрата N-[4-(3-амино-1H-индазол-4-ил)фенил]-N'-(2-фтор-5-метилфенил)мочевины, способы ее получения, композиции, которые ее содержат, и композиции, полученные с ее применением, а также способы лечения пациентов с ее применением.
UAA201006033A 2007-10-19 2008-10-16 Кристаллическое химиотерапевтическое средство на основе индазола UA99746C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98123607P 2007-10-19 2007-10-19

Publications (1)

Publication Number Publication Date
UA99746C2 true UA99746C2 (ru) 2012-09-25

Family

ID=40090209

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201006033A UA99746C2 (ru) 2007-10-19 2008-10-16 Кристаллическое химиотерапевтическое средство на основе индазола

Country Status (24)

Country Link
US (2) US7947843B2 (ru)
EP (1) EP2195298B1 (ru)
JP (1) JP5517940B2 (ru)
KR (1) KR20100085116A (ru)
CN (1) CN101827822B (ru)
AR (1) AR068917A1 (ru)
AU (1) AU2008312529A1 (ru)
BR (1) BRPI0818065A8 (ru)
CA (1) CA2699352C (ru)
CL (1) CL2008003090A1 (ru)
CO (1) CO6280481A2 (ru)
CR (1) CR11388A (ru)
DO (1) DOP2010000115A (ru)
EC (1) ECSP10010188A (ru)
ES (1) ES2460951T3 (ru)
MX (1) MX2010004286A (ru)
PA (1) PA8800201A1 (ru)
PE (1) PE20091385A1 (ru)
RU (1) RU2010119928A (ru)
SG (1) SG185327A1 (ru)
TW (1) TW200934485A (ru)
UA (1) UA99746C2 (ru)
UY (1) UY31407A1 (ru)
WO (1) WO2009052226A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947843B2 (en) * 2007-10-19 2011-05-24 Abbott Laboratories Crystalline chemotherapeutic
US8759538B1 (en) 2013-06-13 2014-06-24 Abbvie Inc. Crystalline chemotherapeutic

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297709B2 (en) * 2003-05-22 2007-11-20 Abbott Laboratories Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
NZ543614A (en) * 2003-05-22 2009-09-25 Abbott Lab Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
JP5066446B2 (ja) * 2005-08-01 2012-11-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 血管新生阻害物質の効果を予測する方法
EP1925676A4 (en) * 2005-08-02 2010-11-10 Eisai R&D Man Co Ltd TEST METHOD FOR THE EFFECT OF A VASCULARIZATION INHIBITOR
CA2626579A1 (en) 2005-10-25 2007-05-03 Abbott Laboratories Formulation comprising a drug of low water solubility and method of use thereof
US20070149593A1 (en) * 2005-12-23 2007-06-28 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
US20100143459A1 (en) * 2006-11-09 2010-06-10 Abbott Gmbh & Co. Kg Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
US7947843B2 (en) * 2007-10-19 2011-05-24 Abbott Laboratories Crystalline chemotherapeutic

Also Published As

Publication number Publication date
RU2010119928A (ru) 2011-11-27
PA8800201A1 (es) 2009-05-15
JP5517940B2 (ja) 2014-06-11
US7947843B2 (en) 2011-05-24
US20090118344A1 (en) 2009-05-07
CN101827822B (zh) 2013-06-19
CR11388A (es) 2010-10-05
AU2008312529A1 (en) 2009-04-23
TW200934485A (en) 2009-08-16
WO2009052226A1 (en) 2009-04-23
EP2195298B1 (en) 2014-02-19
US8486988B2 (en) 2013-07-16
ECSP10010188A (es) 2010-06-29
ES2460951T3 (es) 2014-05-16
CL2008003090A1 (es) 2009-11-27
KR20100085116A (ko) 2010-07-28
DOP2010000115A (es) 2010-10-15
BRPI0818065A8 (pt) 2016-03-08
CA2699352C (en) 2016-06-21
EP2195298A1 (en) 2010-06-16
CN101827822A (zh) 2010-09-08
CO6280481A2 (es) 2011-05-20
BRPI0818065A2 (pt) 2015-03-31
AR068917A1 (es) 2009-12-16
PE20091385A1 (es) 2009-11-12
JP2011500705A (ja) 2011-01-06
MX2010004286A (es) 2010-04-30
UY31407A1 (es) 2009-05-29
US20110196010A1 (en) 2011-08-11
SG185327A1 (en) 2012-11-29
CA2699352A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
DK2092065T3 (da) Antisense-forbindelser
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
UA99489C2 (en) Crystalline chemotherapeutic agent
MX2010004287A (es) Productos quimioterapeuticos cristalinos.
UA101961C2 (en) 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
UA99746C2 (ru) Кристаллическое химиотерапевтическое средство на основе индазола
MX2007004259A (es) Uso de compuestos organicos.
MX2010004288A (es) Productos quimioterapeuticos cristalinos.
MX2010003771A (es) Forma cristalina 2 - de 2 ((r)-2-metilpirrolidin-2-il)-1h-benzimid azol-4-carboxamida.
UA99487C2 (xx) Кристалічний хіміотерапевтичний засіб$кристаллическое химиотерапевтическое средство
TN2011000037A1 (en) Treatment of pulmonary arterial hypertension
TN2011000092A1 (en) Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide